PV-1019

N/A

Report date: 2024/12/05 14:01:59
NME

Base Information

Drug NamePV-1019
Drug Alias NamePV-1019
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCheckpoint kinase 2 inhibitors
TargetsCheckpoint kinase 2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProvid Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesProvid Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A